About respiratory disease testing The respiratory system of the body plays a vital role in eliminating carbon dioxide and toxic wastes, regulates the temperature, and establishes a stabilized blood acid-alkaline balance. Respiratory diseases such as asthma, bronchitis, COPD occur due to acute or chronic defects in the respiratory system. The respiratory testing devices help in detecting chronic or acute respiratory diseases; therefore, the necessary treatment can be provided to people suffering from respiratory damages. Respiratory tests such as imaging, spirometry, peak flow test, blood gas test, lung volume, and few other tests are used to diagnose the respiratory disease. Globally, there has been growing incidences of respiratory diseases such as asthma and COPD. Around 235 million people globally are suffering from asthma, and there have been around 3 million deaths worldwide due to COPD. This indicates an alarming increase in the respiratory disorders worldwide due to high pollution and increased tobacco consumption. These factors result in increased demand for the respiratory testing devices and propel the market growth. Technavio's analysts... Research Beam Model: Research Beam Product ID: 356777 2500 USD New
Global Respiratory Disease Testing Market 2015-2019
 
 

Global Respiratory Disease Testing Market 2015-2019

  • Category : Diagnostic and Biotech
  • Published On : November   2015
  • Pages : 66
  • Publisher : Technavio
 
 
 
About respiratory disease testing
The respiratory system of the body plays a vital role in eliminating carbon dioxide and toxic wastes, regulates the temperature, and establishes a stabilized blood acid-alkaline balance. Respiratory diseases such as asthma, bronchitis, COPD occur due to acute or chronic defects in the respiratory system. The respiratory testing devices help in detecting chronic or acute respiratory diseases; therefore, the necessary treatment can be provided to people suffering from respiratory damages.

Respiratory tests such as imaging, spirometry, peak flow test, blood gas test, lung volume, and few other tests are used to diagnose the respiratory disease. Globally, there has been growing incidences of respiratory diseases such as asthma and COPD. Around 235 million people globally are suffering from asthma, and there have been around 3 million deaths worldwide due to COPD. This indicates an alarming increase in the respiratory disorders worldwide due to high pollution and increased tobacco consumption.
These factors result in increased demand for the respiratory testing devices and propel the market growth.

Technavio's analysts forecast the global respiratory disease testing market to grow at a CAGR of 7.46% over the period 2014-2019.

Covered in this report
The report covers the current scenario and the growth prospects of the global respiratory disease testing market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of testing devices used to diagnose acute and chronic respiratory diseases.

The market is segmented based on the type of test:
Mechanical/screening tests
• Spirometry test
• Peak flow test
• Blood gas test
• Lung volume test
• OSA diagnostic tests
IVD tests
• Molecular diagnostic test
• POC test
• Others

Technavio's report, Global Respiratory Disease Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA, and APAC; it also covers the landscape of the global respiratory disease testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
• Americas
• APAC
• EMEA

Key vendors
• Alere
• CareFusion
• Nihon Kohden
• Philips Healthcare
• Smiths Medical

Other prominent vendors
• Abbott
• Affymetrix
• Cepheid
• COSMED
• Covidien
• F. Hoffmann-La Roche
• Futuremed America
• Instrumentation Laboratories
• ndd Medical Technology
• SDI Diagnostics
• Seegene
• Siemens Healthcare

Key market driver
• Increase in respiratory disorders worldwide
• For a full, detailed list, view our report

Key market challenge
• Use of low-cost testing products
• For a full, detailed list, view our report

Key market trend
• Initiatives and programs to create awareness
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Market landscape
Market overview
Five forces analysis

PART 06: Market segmentation by test

PART 07: Market segmentation by mechanical and screening test
Market size and forecast

PART 08: Market segmentation by IVD test
Molecular diagnostic tests
POC tests
Other tests

PART 09: Geographical segmentation
Global respiratory testing market segmentation by geography

PART 10: Market drivers
Prevalence of chronic respiratory diseases
Rise in air pollution
Increased consumption of tobacco
Government measures for improving healthcare services

PART 11: Impact of drivers

PART 12: Market challenges
Use of cost-effective products
Biocompatibility complications during product design
Lack of standard procedure and funds
Pricing pressure through price ceilings

PART 13: Impact of drivers and challenges

PART 14: Market trends
Initiatives and programs to spread awareness
Use of multiplex devices
Preference for portable devices
Popularity of POC devices

PART 15: Vendor landscape
Competitive scenario
Key prominent vendors
Other prominent vendors

PART 16: Key vendor analysis
Alere
CareFusion
Nihon Kohden
Philips Healthcare
Smiths Medical

PART 17: Appendix
List of abbreviations

PART 18: Explore Technavio

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Overview of global respiratory disease testing market
Exhibit 03: Global respiratory disease testing market 2014-2019 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global respiratory disease testing market by test
Exhibit 06: Global respiratory disease testing market by test type 2014
Exhibit 07: Global respiratory disease testing market by mechanical and screening test 2014-2019 ($ billions)
Exhibit 08: Global respiratory disease testing market by spirometry 2014-2019 ($ millions)
Exhibit 09: Global respiratory disease testing market by peak flow test 2014-2019 ($ millions)
Exhibit 10: Global respiratory disease testing market by blood gas test 2014-2019 ($ millions)
Exhibit 11: Global respiratory disease testing market by pulmonary function test 2014-2019 ($ millions)
Exhibit 12: Global respiratory disease testing market by OSA diagnostic test 2014-2019 ($ millions)
Exhibit 13: Global respiratory disease testing market by IVD test 2014
Exhibit 14: Global respiratory disease testing market segmentation by geography 2014
Exhibit 15: Respiratory disease testing market in Americas 2014-2019 ($ billions)
Exhibit 16: Respiratory disease testing market in EMEA 2014-2019 ($ billions)
Exhibit 17: Respiratory disease testing market in APAC 2014-2019 ($ billions)
Exhibit 18: Impact of drivers
Exhibit 19: Impact of drivers and challenges
Exhibit 20: Alere: Key takeaways
Exhibit 21: CareFusion: Key takeaways
Exhibit 22: Nihon Kohden: Key takeaways
Exhibit 23: Philips Healthcare: Key takeaways
Exhibit 24: Smiths Medical: Key takeaways
Exhibit 25: Alere: Business segmentation by revenue 2014
Exhibit 26: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 27: Alere: Geographical segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 28: Nihon Kohden: Business segmentation by revenue 2015
Exhibit 29: Nihon Kohden: Business segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 30: Nihon Kohden: Geographical segmentation by revenue 2015
Exhibit 31: Philips Healthcare: Business segmentation by revenue 2014
Exhibit 32: Smiths Medical: Business segmentation by revenue 2014
Exhibit 33: Smiths Medical: Business segmentation by revenue 2013 and 2014 ($ billions)

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT